Hoth Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Hoth Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q2 2024.
  • Hoth Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $7.05K, a 27.6% decline year-over-year.
  • Hoth Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $216K, a 65.1% decline from 2022.
  • Hoth Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $621K, a 53.1% decline from 2021.
  • Hoth Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.32M, a 79.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.05K -$2.69K -27.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q4 2023 $216K $5.79K -$9.68K -62.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $226K $190K +$178K +1440% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $48.2K $9.75K -$5.79K -37.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $54K $10.6K -$567K -98.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $621K $15.5K -$111K -87.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $731K $12.4K -$28.1K -69.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $759K $15.5K -$14.8K -48.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $774K $577K -$549K -48.7% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.32M $126K +$174K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $1.15M $40.4K -$621K -93.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.77M $30.4K +$14.3K +88.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $1.76M $1.13M +$1.02M +940% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $738K -$47.8K -$2.05M -102% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $2.78M $661K +$454K +220% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.33M $16.1K -$71.3K -81.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $2.4M $108K -$94.4K -46.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $2.5M $2M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $207K +$201K +3599% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $87.4K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $203K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q3 2018 $5.59K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.